• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder.

Declarative memory impairments are common in patients with bipolar illness, suggesting underlying hippocampal pathology. However, hippocampal volume deficits are rarely observed in bipolar disorder. Here we used surface-based anatomic mapping to examine hippocampal anatomy in bipolar patients treated with lithium relative to matched control subjects and unmedicated patients with bipolar disorder. High-resolution brain magnetic resonance images were acquired from 33 patients with bipolar disorder (21 treated with lithium and 12 unmedicated), and 62 demographically matched healthy control subjects. Three-dimensional parametric mesh models were created from manual tracings of the hippocampal formation. Total hippocampal volume was significantly larger in lithium-treated bipolar patients compared with healthy controls (by 10.3%; p=0.001) and unmedicated bipolar patients (by 13.9%; p=0.003). Statistical mapping results, confirmed by permutation testing, revealed localized deficits in the right hippocampus, in regions corresponding primarily to cornu ammonis 1 subfields, in unmedicated bipolar patients, as compared to both normal controls (p=0.01), and in lithium-treated bipolar patients (p=0.03). These findings demonstrate the sensitivity of these anatomic mapping methods for detecting subtle alterations in hippocampal structure in bipolar disorder. The observed reduction in subregions of the hippocampus in unmedicated bipolar patients suggests a possible neural correlate for memory deficits frequently reported in this illness. Moreover, increased hippocampal volume in lithium-treated bipolar patients may reflect postulated neurotrophic effects of this agent, a possibility warranting further study in longitudinal investigations.

Pubmed ID: 17687266

Authors

  • Bearden CE
  • Thompson PM
  • Dutton RA
  • Frey BN
  • Peluso MA
  • Nicoletti M
  • Dierschke N
  • Hayashi KM
  • Klunder AD
  • Glahn DC
  • Brambilla P
  • Sassi RB
  • Mallinger AG
  • Soares JC

Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Publication Data

May 14, 2008

Associated Grants

  • Agency: NIA NIH HHS, Id: AG016570
  • Agency: NIBIB NIH HHS, Id: EB01651
  • Agency: NICHD NIH HHS, Id: HD050735
  • Agency: NIMH NIH HHS, Id: K23 MH074644-01
  • Agency: NIMH NIH HHS, Id: MH 01736
  • Agency: NIMH NIH HHS, Id: MH 30915
  • Agency: NCRR NIH HHS, Id: RR019771
  • Agency: NCRR NIH HHS, Id: RR020571

Mesh Terms

  • Adolescent
  • Adult
  • Aged
  • Antidepressive Agents
  • Bipolar Disorder
  • Brain Mapping
  • Female
  • Hippocampus
  • Humans
  • Imaging, Three-Dimensional
  • Lithium Compounds
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged